Arizona State Retirement System Kymera Therapeutics, Inc. Transaction History

Arizona State Retirement System

$14.8 Billion
Q2 2024

A detailed history of Arizona State Retirement System transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 12,830 shares of KYMR stock, worth $606,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,830

Previous 11,100 15.59%

Holding current value

$606,859

Previous $446,000 14.35%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$29.85 - $39.42 $51,640 - $68,196	1,730 Added 15.59%	12,830 $382,000
Q1 2024 May 07, 2024	BUY	$22.9 - $43.57 $23,609 - $44,920	1,031 Added 10.24%	11,100 $446,000
Q4 2023 Jan 24, 2024	SELL	$10.97 - $26.84 $1,831 - $4,482	-167 Reduced 1.63%	10,069 $256,000
Q3 2023 Nov 06, 2023	BUY	$13.9 - $23.88 $142,280 - $244,435	10,236 New	10,236 $142,000
Q1 2023 Apr 27, 2023	BUY	$24.84 - $38.75 $20,393 - $31,813	821 Added 8.63%	10,333 $306,000
Q4 2022 Feb 07, 2023	BUY	$19.57 - $30.92 $186,149 - $294,111	9,512 New	9,512 $237,000
Q2 2022 Jul 28, 2022	SELL	$14.13 - $42.55 $107,953 - $325,082	-7,640 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$35.3 - $64.68 $3,000 - $5,497	85 Added 1.13%	7,640 $323,000
Q4 2021 Feb 04, 2022	BUY	$49.91 - $65.56 $4,791 - $6,293	96 Added 1.29%	7,555 $480,000
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $356,540 - $497,216	7,459 New	7,459 $438,000
Q1 2021 May 06, 2021	SELL	$35.64 - $85.46 $115,045 - $275,864	-3,228 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$28.07 - $87.83 $90,609 - $283,515	3,228 New	3,228 $200,000

Others Institutions Holding KYMR

# of Institutions

160

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.59B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Kymera Therapeutics, Inc. Transaction History